Introduction: Fibromyalgia syndrome (FMS) is a chronic disease characterized by widespread musculoskeletal pain and hypersensitivity at some points of the body. The aim of our study is to investigate whether there is a difference between male and female FMS patients and male and female healthy volunteers in terms of dermatological findings. Methods: Sixty female and 60 male patients, who were diagnosed with FMS, were included in the study group; 60 female and 60 male healthy volunteers were included in the control group. Fibromyalgia Impact Questionnaire and Beck Depression Inventory were applied to all participants at the time of admission. All participants were examined by a dermatologist and dermatological diagnoses were recorded. The results of the patients in both groups were compared and statistically analyzed. Results: In the examination of dermatological diagnoses, it was found that the incidence of lichen simplex chronicus was significantly higher in female FMS patients than in healthy female participants (p=0.006). Discussion and Conclusion: Based on the results of this study, we believe that dermatological examination in patients with FMS should be given more importance within a holistic examination approach.
F ibromyalgia syndrome (FMS) is a widespread and chronic disease characterized by chronic widespread musculoskeletal pain and hypersensitivity at some points of the body, which are called sensitive points [1] . FMS can accompany many disorders with a widespread pathogenetic mechanism such as irritable bowel syndrome, chronic fatigue syndrome, anxiety, and depression [2] . Apart from these symptoms, pathological examination of the skin in patients with FMS revealed the presence of oxidative stress in the skin and various changes such as an increased number of cytokines and mast cells [3] .
FMS is not considered to be a disorder with dermatological findings. However, several studies have shown that there are objective differences in the skin of patients with FMS compared with that of healthy subjects [4] . In particular, researchers have reported increased mast cell degranulation and increased mast cell count in the skin of patients with FMS compared with that of healthy volunteers [5] . 
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Increased inflammatory cytokines in the skin [6] , modified collagen metabolism due to the accumulation of collagen around peripheral nerves [7] , cutaneous microcirculatory abnormalities [5, 6] , autonomic nervous system dysfunction, and high levels of cutaneous opioid receptors [8] have also been reported. All of these are considered to constitute the dermatological findings of FMS patients [9] .
Our aim is to classify dermatological findings in male and female FMS patients and to determine whether there is any difference compared with the control group in terms of dermatological diseases.
Materials and Methods
Patients who were admitted to Algology, Rheumatology, Physical Medicine, and Rehabilitation outpatient clinics and diagnosed with FMS based on the American College of Rheumatology (ACR) 2016 criteria [10] were included in the study. Sixty female and 60 male patients with FMS were included in the study group; 60 healthy female and 60 healthy male volunteers were included in the control group.
Demographic data of all participants were recorded. Fibromyalgia Impact Questionnaire (FIQ) and Beck Depression Inventory (BDI) were completed for all participants. Skin examinations of all participants were performed by a dermatology specialist. The dermatological problems of all participants during the examination were recorded, and diagnostic skin diseases were determined and recorded.
Inclusion criteria consisted diagnosis with FMS, ages of 30-50 years, and absence of major psychiatric disorders. Exclusion criteria were presence of comorbid diseases that may be confused with FMS and may create suspicion in the differential diagnosis, presence of serious psychiatric problems, mental retardation, pregnancy or breastfeeding, diagnosis with cancer and receiving cancer treatment, and presence of rheumatic disease.
Informed consent forms were obtained from all participants. The study was approved by the local ethics committee.
Statistical Analysis
The categorical data were compared using chi square test and Fisher's exact test, and the results were presented together with number and frequency values. The normality of continuous data was examined using the Shapiro-Wilk test. Since the data were not normally distributed, intergroup comparisons were performed using the MannWhitney U test. Median (minimum-maximum) values were given as descriptive statistics for the groups. The level of statistical significance was α=0.05. The data were statistically analyzed using SPSS v22.
Results
In terms of demographic variables (age, marital status, and educational status), the groups were homogeneous among themselves (p>0.005) ( Tables 1, 2 , and 3).
There was no significant difference between female patients with FMS and healthy female participants in terms of age (p=0.922), marital status (p=1.000), and educational status (p=0.691). There was a statistically significant difference between female patients with FMS and healthy female par- ticipants in terms of BDI and FIQ scores (p<0.001, p<0.001).
In the examination of dermatological diagnoses, there was a significant difference in patients diagnosed with lichen simplex chronicus in terms of their distribution between the two groups (p=0.006). There was no significant difference in the distribution of other dermatological diagnoses (Table 1) .
There was no significant difference between male FMS patients and healthy male participants in terms of age (p=0.933), marital status (p=1.000), and educational status (p=0.987). There was a statistically significant difference between male FMS patients and healthy male participants in terms of BDI and FIQ scores (p<0.001, p<0.001). This difference was due to high BDI and FIQ scores of male FMS patients. There was no significant difference between the two groups in terms of dermatological diagnoses (Table 2 ).
There was no significant difference between male FMS patients and female FMS patients in terms of age (p=0.931), marital status (p=1.000), and educational status (p=0.694).
There was a statistically significant difference between the BDI scores of male FMS patients and female FMS patients (p<0.001). Similarly, there was a significant difference between the FIQ scores of two groups (p=0.074). There was no significant difference between the two groups in terms of dermatological diagnoses (Table 3) . 
Discussion
The aim of our study was to determine whether there is a difference in dermatological findings between male and female FMS patients and healthy volunteers and between male and female FMS patients. The most significant result of our study was that the diagnosis of lichen simplex chronicus was significantly higher in female FMS patients than in healthy female participants (p=0.006). This difference suggested that patients with FMS were more prone to dermatological diseases.
There was a statistically significant difference between BDI and FIQ scores of female FMS patients and healthy female participants (p<0.001, p<0.001). However, this difference due to high BDI and FIQ scores in patients with FMS was an expected result due to the presence of the disease in the study group. In addition, there was a statistically significant difference between BDI and FIQ scores of male FMS patients and healthy male participants (p<0.001, p<0.001). These results were also an expected result due to the diagnosis of FMS. There was a significant difference between female FMS patients and male FMS patients in terms of BDI scores (p<0.001). This result revealed that female FMS patients were more prone to depression. In addition, BDI and FIQ scores in both female and male FMS patients were found to be consistent with those in the literature [11, 12] .
Previous studies have reported increased mast cell counts, inflammatory cytokines, opioid receptors, dysfunctional mitochondria, and structural and functional disorders in the skin of patients with FMS. In studies with no increase in mast cell count, mast cell degranulation and immunoglobulin G levels were found to be increased. An increase in interleukin 1β, interleukin-6, tumor necrosis factor-α, and oxidative stress parameters and a decrease in coenzyme Q10 levels were detected in the skin samples. Therefore, dermatological findings in FMS patients vary widely [13] [14] [15] .
In a study by Laniosz et al. [16] with 825 FMS patients, no dermatological diagnosis was dominant in this population, except for a subjective increase in sweating (32%). In the same study, patients diagnosed with lichen simplex chronicus were found to constitute 0.5% of the FMS population, whereas in our study, patients with lichen simplex chronicus were found to constitute 10.5% of the female FMS group and 5% of the male FMS group.
In a study by Thune, only 35 of 105 patients with FMS had a previous diagnosis of psoriasis [17] . In our study, the patients diagnosed with psoriasis were found to constitute 0.5% of the male FMS group, and psoriasis was not detected in the female FMS group.
In a study by Torresani et al., [18] chronic urticaria was found in 70% of 126 FMS patients. Yener et al. [19] investigated the rate of FMS in 72 patients with chronic urticaria. In this study, there was no significant difference between the rate of FMS in the control group and in patients with chronic urticaria. However, this rate was found to be 10% in the female FMS group and 7.5% in the male FMS group in our study. Future studies with larger sample sizes are needed to investigate this issue.
In a study by Erdogan et al., [20] 105 FMS patients and 105 healthy volunteers were compared in terms of xerosis, dermographism, lichen simplex chronicus, neurotic excoriations, tinea pedis, and seborrheic dermatitis. These diagnoses were significantly higher in the FMS group than in the control group. In our study, the rate of lichen simplex chronicus diagnosis in the female FMS group was found to be 10.5%. This rate was significantly higher than that in healthy female participants.
In our study, lichen simplex chronicus was found to be more common in the FMS group. In addition, BDI scores were also significantly higher in the female FMS group than in the female control and male FMS groups. In other studies, lichen simplex chronicus has been usually comorbid with obsessive compulsive disease and anxiety. Similarly, FMS has been associated with major depression, anxiety, and psychiatric disorders [21] [22] [23] [24] . This explains why lichen simplex chronicus is more common in the female FMS group.
Conclusion
In our study, we found that lichen simplex chronicus was more common in female FMS patients. When evaluating patients with FMS, clinicians should follow a holistic approach both psychologically and dermatologically and increase their awareness in this respect.
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